{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,20]],"date-time":"2026-03-20T00:11:15Z","timestamp":1773965475228,"version":"3.50.1"},"reference-count":83,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2015,4,30]],"date-time":"2015-04-30T00:00:00Z","timestamp":1430352000000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Pediatr Nephrol"],"published-print":{"date-parts":[[2016,2]]},"DOI":"10.1007\/s00467-015-3082-x","type":"journal-article","created":{"date-parts":[[2015,4,29]],"date-time":"2015-04-29T05:56:38Z","timestamp":1430286998000},"page":"207-215","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":75,"title":["The glomerular permeability factors in idiopathic nephrotic syndrome"],"prefix":"10.1007","volume":"31","author":[{"given":"Jean-Claude","family":"Davin","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2015,4,30]]},"reference":[{"key":"3082_CR1","doi-asserted-by":"crossref","unstructured":"International Study of Kidney Disease in Children (1978) Nephrotic syndrome in children: prediction of histopathology from clinical and laboratory characteristics at time of diagnosis. Kidney Int 13:159\u2013165","DOI":"10.1038\/ki.1978.23"},{"key":"3082_CR2","doi-asserted-by":"crossref","first-page":"1353","DOI":"10.1016\/S0140-6736(70)91268-7","volume":"1","author":"RH White","year":"1970","unstructured":"White RH, Glasgow EF, Mills RJ (1970) Clinicopathological study of nephrotic syndrome in childhood. Lancet 1:1353\u20131359","journal-title":"Lancet"},{"key":"3082_CR3","first-page":"543","volume-title":"Paediatric nephrology","author":"P Niaudet","year":"2004","unstructured":"Niaudet P (2004) Steroid-sensitive nephrotic syndrome in children. In: Avner ED, Harmon WE, Neasden P (eds) Paediatric nephrology. Lippincott Williams and Wilkins, Philadelphia, pp 543\u2013556"},{"key":"3082_CR4","first-page":"11","volume":"4","author":"DS Gipson","year":"2013","unstructured":"Gipson DS, Selewski DT, Massengill SF, Wickman L, Messer KL, Herreshoff E, Bowers C, Ferris ME, Mahan JD, Greenbaum LA, MacHardy J, Kapur G, Chand DH, Goebel J, Barletta GM, Geary D, Kershaw DB, Pan CG, Gbadegesin R, Hidalgo G, Lane JC, Leiser JD, Plattner BW, Song PX, Thissen D, Liu Y, Gross HE, DeWalt DA (2013) Gaining the PROMIS perspective from children with nephrotic syndrome: a Midwest pediatric nephrology consortium study. Health Qual Life Outcomes 4:11\u201330. doi: 10.1186\/1477-7525-11-30","journal-title":"Health Qual Life Outcomes"},{"key":"3082_CR5","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1016\/S0022-3476(81)80760-3","volume":"98","author":"HL Barnett","year":"1981","unstructured":"Barnett HL, Edelmann CM, Greifer I (1981) The primary nephrotic syndrome in children. Identification of patients with minimal change nephrotic syndrome from initial response to prednisone. A report of the International Study of Kidney Disease in Children. J Pediatr 98:561\u2013564","journal-title":"J Pediatr"},{"key":"3082_CR6","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1681\/ASN.V85769","volume":"8","author":"P Tarshish","year":"1997","unstructured":"Tarshish P, Tobin JN, Bernstein J, Edelmann CM Jr (1997) Prognostic significance of the early course of minimal change nephrotic syndrome: report of the International Study of Kidney Disease in Children. J Am Soc Nephrol 8:769\u2013776","journal-title":"J Am Soc Nephrol"},{"key":"3082_CR7","doi-asserted-by":"crossref","first-page":"2183","DOI":"10.1093\/ndt\/gfm092","volume":"22","author":"JH Ehrich","year":"2007","unstructured":"Ehrich JH, Geerlings C, Zivicnjak M, Franke D, Geerlings H, Gellermann J (2007) Steroid-resistant idiopathic childhood nephrosis: overdiagnosed and undertreated. Nephrol Dial Transplant 22:2183\u20132193","journal-title":"Nephrol Dial Transplant"},{"key":"3082_CR8","author":"CE Sadowski","year":"2014","unstructured":"Sadowski CE, Lovric S, Ashraf S, Pabst WL, Gee HY, Kohl S, Engelmann S, Vega-Warner V, Fang H, Halbritter J, Somers MJ, Tan W, Shril S, Fessi I, Lifton RP, Bockenhauer D, El-Desoky S, Kari JA, Zenker M, Kemper MJ, Mueller D, Fathy HM, Soliman NA, the SRNS Study Group, Hildebrandt F (2014) A single-gene cause in 29.5% of cases of steroid-resistant nephrotic syndrome. J Am Soc Nephrol. doi: 10.1681\/ASN.2014050489","journal-title":"J Am Soc Nephrol"},{"key":"3082_CR9","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1681\/ASN.2013111155","volume":"26","author":"S Giglio","year":"2015","unstructured":"Giglio S, Provenzano A, Mazzinghi B, Becherucci F, Giunti L, Sansavini G, Ravaglia F, Roperto RM, Farsetti S, Benetti E, Rotondi M, Murer L, Lazzeri E, Lasagni L, Materassi M, Romagnani P (2015) Heterogeneous genetic alterations in sporadic nephrotic syndrome associate with resistance to immunosuppression. J Am Soc Nephrol 26:230\u2013236","journal-title":"J Am Soc Nephrol"},{"key":"3082_CR10","doi-asserted-by":"crossref","first-page":"31","DOI":"10.2215\/CJN.02690806","volume":"2","author":"N He","year":"2007","unstructured":"He N, Zahirieh A, Mei Y, Lee B, Senthilnathan S, Wong B, Mucha B, Hildebrandt F, Cole DE, Cattran D, Pei Y (2007) Recessive NPHS2 (Podocin) mutations are rare in adult-onset idiopathic focal segmental glomerulosclerosis. Clin J Am Soc Nephrol 2:31\u201337","journal-title":"Clin J Am Soc Nephrol"},{"key":"3082_CR11","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1002\/humu.22485","volume":"35","author":"K Bouchireb","year":"2013","unstructured":"Bouchireb K, Boyer O, Gribouval O, Nevo F, Huynh-Cong E, Morini\u00e8re V, Campait R, Ars E, Brackman D, Dantal J, Eckart P, Gigante M, Lipska BS, Liutkus A, Megarbane A, Mohsin N, Ozaltin F, Saleem MA, Schaefer F, Soulami K, Torra R, Garcelon N, Mollet G, Dahan K, Antignac C (2013) NPHS2 mutations in steroid-resistant nephrotic syndrome: a mutation update and the associated phenotypic spectrum. Hum Mutat 35:178\u2013186","journal-title":"Hum Mutat"},{"key":"3082_CR12","doi-asserted-by":"crossref","first-page":"844","DOI":"10.1111\/apa.12317","volume":"102","author":"S Joshi","year":"2013","unstructured":"Joshi S, Andersen R, Jespersen B, Rittig S (2013) Genetics of steroid-resistant nephrotic syndrome: a review of mutation spectrum and suggested approach for genetic testing. Acta Paediatr 102:844\u2013856","journal-title":"Acta Paediatr"},{"key":"3082_CR13","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1038\/nm.1857","volume":"14","author":"C Faul","year":"2008","unstructured":"Faul C, Donnelly M, Merscher-Gomez S, Chang YH, Franz S, Delfgaauw J, Chang JM, Choi HY, Campbell KN, Kim K, Reiser J, Mundel P (2008) The actin cytoskeleton of kidney podocytes is a direct target of the antiproteinuric effect of cyclosporine A. Nat Med 14:931\u2013938","journal-title":"Nat Med"},{"key":"3082_CR14","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1056\/NEJM200102013440517","volume":"344","author":"MJ Kemper","year":"2001","unstructured":"Kemper MJ, Wolf G, M\u00fcller-Wiefel DE (2001) Transmission of glomerular permeability factor from a mother to her child. N Engl J Med 344:386\u2013387","journal-title":"N Engl J Med"},{"issue":"366","key":"3082_CR15","doi-asserted-by":"crossref","first-page":"1648","DOI":"10.1056\/NEJMc1202500","volume":"26","author":"L Gallon","year":"2012","unstructured":"Gallon L, Leventhal J, Skaro A, Kanwar Y, Alvarado A (2012) Resolution of recurrent focal segmental glomerulosclerosis after retransplantation. N Engl J Med 26(366):1648\u20131649","journal-title":"N Engl J Med"},{"key":"3082_CR16","doi-asserted-by":"crossref","first-page":"2115","DOI":"10.2215\/CJN.03800609","volume":"5","author":"ET McCarthy","year":"2010","unstructured":"McCarthy ET, Sharma M, Savin VJ (2010) Circulating permeability factors in idiopathic nephrotic syndrome and focal segmental glomerulosclerosis. Clin J Am Soc Nephrol 5:2115\u20132121","journal-title":"Clin J Am Soc Nephrol"},{"key":"3082_CR17","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1007\/s00467-006-0361-6","volume":"22","author":"RN Fine","year":"2007","unstructured":"Fine RN (2007) Recurrence of nephrotic syndrome\/focal segmental glomerulosclerosis following renal transplantation in children. Pediatr Nephrol 22:496\u2013502","journal-title":"Pediatr Nephrol"},{"key":"3082_CR18","doi-asserted-by":"crossref","first-page":"2907","DOI":"10.1111\/j.1600-6143.2005.01112.x","volume":"5","author":"RY Gohh","year":"2005","unstructured":"Gohh RY, Yango AF, Morrissey PE, Monaco AP, Gautam A, Sharma M, McCarthy ET, Savin VJ (2005) Preemptive plasmapheresis and recurrence of FSGS in high-risk renal transplant recipients. Am J Transplant 5:2907\u20132912","journal-title":"Am J Transplant"},{"key":"3082_CR19","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1097\/00007890-200202150-00013","volume":"73","author":"J Patrakka","year":"2002","unstructured":"Patrakka J, Ruotsalainen V, Reponen P, Qvist E, Laine J, Holmberg C, Tryggvason K, Jalanko H (2002) Recurrence of nephrotic syndrome in kidney grafts of patients with congenital nephrotic syndrome of the Finnish type: role of nephrin. Transplantation 73:394\u2013403","journal-title":"Transplantation"},{"key":"3082_CR20","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1007\/BF00915067","volume":"2","author":"C Lenarsky","year":"1982","unstructured":"Lenarsky C, Jordan SC, Ladisch S (1982) Plasma inhibition of lymphocyte proliferation in nephrotic syndrome: correlation with hyperlipidemia. J Clin Immunol 2:276\u2013281","journal-title":"J Clin Immunol"},{"key":"3082_CR21","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1016\/S0140-6736(74)91880-7","volume":"2","author":"RJ Shalhoub","year":"1974","unstructured":"Shalhoub RJ (1974) Pathogenesis of lipoid nephrosis: a disorder of T cell function. Lancet 2:556\u2013560","journal-title":"Lancet"},{"key":"3082_CR22","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1042\/CS20040095","volume":"107","author":"JG Berg Van den","year":"2004","unstructured":"Van den Berg JG, Weening JJ (2004) Role of the immune system in the pathogenesis of idiopathic nephrotic syndrome. Clin Sci 107:125\u2013136","journal-title":"Clin Sci"},{"key":"3082_CR23","first-page":"37","volume":"23","author":"G Lagrue","year":"1975","unstructured":"Lagrue G, Xheneumont S, Branellec A, Hirbec G, Weil B (1975) A vascular permeability factor elaborated from lymphocytes. I. Demonstration in patients with nephrotic syndrome. Biomedicine 23:37\u201340","journal-title":"Biomedicine"},{"key":"3082_CR24","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1046\/j.1523-1755.2000.00870.x","volume":"57","author":"C Frank","year":"2000","unstructured":"Frank C, Herrmann M, Fernandez S, Dirnecker D, B\u00f6swald M, Kolowos W, Ruder H, Haas JP (2000) Dominant T cells in idiopathic nephrotic syndrome of childhood. Kidney Int 57:510\u2013517","journal-title":"Kidney Int"},{"key":"3082_CR25","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1159\/000313947","volume":"169","author":"SY Zhang","year":"2011","unstructured":"Zhang SY, Audard V, Fan Q, Pawlak A, Lang P, Sahali D (2011) Immunopathogenesis of idiopathic nephrotic Syndrome. Contrib Nephrol 169:94\u2013106","journal-title":"Contrib Nephrol"},{"key":"3082_CR26","doi-asserted-by":"crossref","first-page":"1497","DOI":"10.1002\/eji.1830250604","volume":"25","author":"H Kimata","year":"1995","unstructured":"Kimata H, Fujimoto M, Furusho K (1995) Involvement of interleukin (IL)-13, but not IL-4, in spontaneous IgE and IgG4 production in nephrotic syndrome. Eur J Immunol 25:1497\u20131501","journal-title":"Eur J Immunol"},{"key":"3082_CR27","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1681\/ASN.V103529","volume":"10","author":"HK Yap","year":"1999","unstructured":"Yap HK, Cheung W, Murugasu B, Sim SK, Seah CC, Jordan SC (1999) Th1 and Th2 cytokine mRNA profiles in childhood nephrotic syndrome: evidence for increased IL-13 mRNA expression in relapse. J Am Soc Nephrol 10:529\u2013537","journal-title":"J Am Soc Nephrol"},{"key":"3082_CR28","doi-asserted-by":"crossref","first-page":"1476","DOI":"10.1681\/ASN.2006070710","volume":"18","author":"KW Lai","year":"2007","unstructured":"Lai KW, Wei CL, Tan LK, Tan PH, Chiang GS, Lee CG, Jordan SC, Yap HK (2007) Overexpression of interleukin-13 induces minimal-change-like nephropathy in rats. J Am Soc Nephrol 18:1476\u20131485","journal-title":"J Am Soc Nephrol"},{"key":"3082_CR29","doi-asserted-by":"crossref","first-page":"945","DOI":"10.1053\/j.ajkd.2009.03.019","volume":"54","author":"M Abdel-Hafez","year":"2009","unstructured":"Abdel-Hafez M, Shimada M, Lee PY, Johnson RJ, Garin EH (2009) Idiopathic nephrotic syndrome and atopy: is there a common link? Am J Kidney Dis 54:945\u2013953","journal-title":"Am J Kidney Dis"},{"key":"3082_CR30","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1038\/ki.2010.143","volume":"78","author":"EH Garin","year":"2010","unstructured":"Garin EH, Mu W, Arthur JM, Rivard CJ, Araya CE, Shimada M, Johnson RJ (2010) Urinary CD80 is elevated in minimal change disease but not in focal segmental glomerulosclerosis. Kidney Int 78:296\u2013302","journal-title":"Kidney Int"},{"key":"3082_CR31","doi-asserted-by":"crossref","first-page":"1281","DOI":"10.1007\/s00467-004-1573-2","volume":"19","author":"D Raveh","year":"2004","unstructured":"Raveh D, Shemesh O, Ashkenazi YJ, Winkler R, Barak V (2004) Tumor necrosis factor-\u03b1 blocking agent as a treatment for nephrotic syndrome. Pediatr Nephrol 19:1281\u20131284","journal-title":"Pediatr Nephrol"},{"key":"3082_CR32","doi-asserted-by":"crossref","first-page":"858","DOI":"10.1111\/j.1600-6143.2009.02550.x","volume":"9","author":"S Leroy","year":"2009","unstructured":"Leroy S, Guigonis V, Bruckner D, Emal-Aglae V, Desch\u00eanes G, Bensman A, Ulinski T (2009) Successful anti-TNF\u03b1 treatment in a child with post-transplant recurrent focal segmental glomerulosclerosis. Am J Transplant 9:858\u2013861","journal-title":"Am J Transplant"},{"key":"3082_CR33","doi-asserted-by":"crossref","first-page":"2217","DOI":"10.1007\/s00467-012-2163-3","volume":"27","author":"M Bitzan","year":"2012","unstructured":"Bitzan M, Babayeva S, Vasudevan A, Goodyer P, Torban E (2012) TNFalpha pathway blockade ameliorates toxic effects of FSGS plasma on podocyte cytoskeleton and beta3 integrin activation. Pediatr Nephrol 27:2217\u20132226","journal-title":"Pediatr Nephrol"},{"key":"3082_CR34","doi-asserted-by":"crossref","first-page":"1269","DOI":"10.1007\/s00467-008-0814-1","volume":"23","author":"V Guigonis","year":"2008","unstructured":"Guigonis V, Dallocchio A, Baudouin V, Dehennault M, Hachon-Le Camus C, Afanetti M, Groothoff J, Llanas B, Niaudet P, Nivet H, Raynaud N, Taque S, Ronco P, Bouissou F (2008) Rituximab treatment for severe steroid- or cyclosporine-dependent nephrotic syndrome: a multicentric series of 22 cases. Pediatr Nephrol 23:1269\u20131279","journal-title":"Pediatr Nephrol"},{"key":"3082_CR35","doi-asserted-by":"crossref","first-page":"2207","DOI":"10.2215\/CJN.03470410","volume":"5","author":"A Gulati","year":"2010","unstructured":"Gulati A, Sinha A, Jordan SC, Hari P, Dinda AK, Sharma S, Srivastava RN, Moudgil A, Bagga A (2010) Efficacy and safety of treatment with rituximab for difficult steroid-resistant and -dependent nephrotic syndrome: multicentric report. Clin J Am Soc Nephrol 5:2207\u20132212","journal-title":"Clin J Am Soc Nephrol"},{"key":"3082_CR36","doi-asserted-by":"crossref","first-page":"850","DOI":"10.1681\/ASN.2013030251","volume":"25","author":"P Ruggenenti","year":"2014","unstructured":"Ruggenenti P, Ruggiero B, Cravedi P, Vivarelli M, Massella L, Maras\u00e0 M, Chianca A, Rubis N, Ene-Iordache B, Rudnicki M, Pollastro RM, Capasso G, Pisani A, Pennesi M, Emma F, Remuzzi G, Rituximab in Nephrotic Syndrome of Steroid-Dependent or Frequently Relapsing Minimal Change Disease Or Focal Segmental Glomerulosclerosis (NEMO) Study Group (2014) Rituximab in steroid-dependent or frequently relapsing idiopathic nephrotic syndrome. J Am Soc Nephrol 25:850\u2013863","journal-title":"J Am Soc Nephrol"},{"key":"3082_CR37","doi-asserted-by":"crossref","first-page":"1273","DOI":"10.1016\/S0140-6736(14)60541-9","volume":"384","author":"K Iijima","year":"2014","unstructured":"Iijima K, Sako M, Nozu K, Mori R, Tuchida N, Kamei K, Miura K, Aya K, Nakanishi K, Ohtomo Y, Takahashi S, Tanaka R, Kaito H, Nakamura H, Ishikura K, Ito S, Ohashi Y, On behalf of the Rituximab for Childhood-onset Refractory Nephrotic Syndrome (RCRNS) Study Group (2014) Rituximab for childhood-onset, complicated, frequently relapsing nephrotic syndrome or steroid-dependent nephrotic syndrome: a multicentre, double-blind, randomised, placebo-controlled trial. Lancet 384:1273\u20131281","journal-title":"Lancet"},{"key":"3082_CR38","author":"CE Araya","year":"2011","unstructured":"Araya CE, Dharnidharka VR (2011) The factors that may predict response to rituximab therapy in recurrent focal segmental glomerulosclerosis: a systematic review. J Transplant. doi: 10.1155\/2011\/37421","journal-title":"J Transplant"},{"key":"3082_CR39","doi-asserted-by":"crossref","first-page":"1362","DOI":"10.4049\/jimmunol.180.3.1362","volume":"180","author":"S Deola","year":"2008","unstructured":"Deola S, Panelli MC, Maric D, Selleri S, Dmitrieva NI, Voss CY, Klein H, Stroncek D, Wang E, Marincola FM (2008) Helper B cells promote cytotoxic T cell survival and proliferation independently of antigen presentation through CD27\/CD70 interactions. J Immunol 180:1362\u20131372","journal-title":"J Immunol"},{"key":"3082_CR40","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/j.bihy.2009.03.001","volume":"2","author":"G Desch\u00eanes","year":"2009","unstructured":"Desch\u00eanes G, Doucet A (2009) Free immunoglobulin light chains: a role in minimal change disease. Biosci Hypotheses 2:135\u2013142","journal-title":"Biosci Hypotheses"},{"key":"3082_CR41","doi-asserted-by":"crossref","first-page":"2325","DOI":"10.1007\/s00467-014-2860-1","volume":"29","author":"C Dossier","year":"2014","unstructured":"Dossier C, Sellier-Leclerc AL, Rousseau A, Michel Y, Gautheret-Dejean A, Englender M, Madhi F, Charbit M, Ulinski T, Simon T, Jacqz-Aigrain E, Desch\u00eanes G (2014) Prevalence of herpesviruses at onset of idiopathic nephrotic syndrome. Pediatr Nephrol 29:2325\u20132321","journal-title":"Pediatr Nephrol"},{"key":"3082_CR42","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1111\/j.1365-2249.2005.02862.x","volume":"141","author":"L Musante","year":"2005","unstructured":"Musante L, Candiano G, Bruschi M, Santucci L, Carnemolla B, Orecchia P, Giampuzzi M, Zennaro C, Sanna-Cherchi S, Carraro M, Oleggini R, Camussi G, Perfumo F, Ghiggeri GM (2005) Circulating anti-actin and anti-ATP synthase antibodies identify a sub-set of patients with idiopathic nephrotic syndrome. Clin Exp Immunol 141:491\u2013499","journal-title":"Clin Exp Immunol"},{"key":"3082_CR43","author":"RA Gbadegesin","year":"2014","unstructured":"Gbadegesin RA, Adeyemo A, Webb NJ, Greenbaum LA, Abeyagunawardena A, Thalgahagoda S, Kale A, Gipson D, Srivastava T, Lin JJ, Chand D, Hunley TE, Brophy PD, Bagga A, Sinha A, Rheault MN, Ghali J, Nicholls K, Abraham E, Halima J, Omoloja A, Barletta GM, Cai Y, Milford DD, O\u2019Brien C, Awan A, Belostotsky V, Smoyer WE, Homstad A, Hall G, Wu G, Nagaraj S, Wigfall D, Foreman J, Winn MP, Members of the Mid-West Pediatric Nephrology Consortium (2014) HLA-DQA1 and PLCG2 Are Candidate Risk Loci for Childhood-Onset Steroid-Sensitive Nephrotic Syndrome. J Am Soc Nephrol. doi: 10.1681\/ASN.2014030247","journal-title":"J Am Soc Nephrol"},{"issue":"11","key":"3082_CR44","doi-asserted-by":"crossref","first-page":"5690","DOI":"10.4049\/jimmunol.168.11.5690","volume":"168","author":"G Senaldi","year":"2002","unstructured":"Senaldi G, Stolina M, Guo J, Faggioni R, McCabe S, Kaufman SA, Van G, Xu W, Fletcher FA, Boone T, Chang MS, Sarmiento U, Cattley RC (2002) Regulatory effects of novel neurotrophin-1\/b cell-stimulating factor-3 (cardiotrophin-like cytokine) on B cell function. J Immunol 168(11):5690\u20135698","journal-title":"J Immunol"},{"key":"3082_CR45","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1016\/j.trsl.2008.04.001","volume":"151","author":"VJ Savin","year":"2008","unstructured":"Savin VJ, McCarthy ET, Sharma R, Charba D, Sharma M (2008) Galactose binds to focal segmental glomerulosclerosis permeability factor and inhibits its activity. Transl Res 151:288\u2013292","journal-title":"Transl Res"},{"key":"3082_CR46","doi-asserted-by":"crossref","first-page":"e35","DOI":"10.1097\/TP.0b013e3182088b67","volume":"91","author":"KD Jhaveri","year":"2011","unstructured":"Jhaveri KD, Naber TH, Wang X, Molmenti E, Bhaskaran M, Boctor FN, Trachtman H (2011) Treatment of recurrent focal segmental glomerular sclerosis post-transplant with a multimodal approach including high-galactose diet and oral galactose supplementation. Transplantation 91:e35\u2013e36","journal-title":"Transplantation"},{"key":"3082_CR47","author":"H Trachtman","year":"2011","unstructured":"Trachtman H, Vento S, Gipson D, Wickman L, Gassman J, Joy M, Savin V, Somers M, Pinsk M, Greene T (2011) Novel therapies for resistant focal segmental glomerulosclerosis (FONT) phase II clinical trial: study design. BMC Nephrol. doi: 10.1186\/1471-2369-12-8","journal-title":"BMC Nephrol"},{"key":"3082_CR48","doi-asserted-by":"crossref","first-page":"2131","DOI":"10.1007\/s00467-013-2539-z","volume":"28","author":"K Sgambat","year":"2013","unstructured":"Sgambat K, Banks M, Moudgil A (2013) Effect of galactose on glomerular permeability and proteinuria in steroid-resistant nephrotic syndrome. Pediatr Nephrol 28:2131\u20135","journal-title":"Pediatr Nephrol"},{"key":"3082_CR49","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1007\/s00467-013-2700-8","volume":"29","author":"H Trachtman","year":"2014","unstructured":"Trachtman H, Savin VJ (2014) Galactose treatment in focal segmental glomerulosclerosis. Pediatr Nephrol 29:931","journal-title":"Pediatr Nephrol"},{"key":"3082_CR50","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1681\/ASN.2006090965","volume":"18","author":"L Musante","year":"2007","unstructured":"Musante L, Candiano G, Petretto A, Bruschi M, Dimasi N, Caridi G, Pavone B, Del Boccio P, Galliano M, Urbani A, Scolari F, Vincenti F, Ghiggeri GM (2007) Active focal segmental glomerulosclerosis is associated with massive oxidation of plasma albumin. J Am Soc Nephrol 18:799\u2013810","journal-title":"J Am Soc Nephrol"},{"key":"3082_CR51","doi-asserted-by":"crossref","first-page":"2735","DOI":"10.1111\/j.1523-1755.2005.00744.x","volume":"68","author":"M Sharma","year":"2005","unstructured":"Sharma M, McCarthy ET, Savin VJ, Lianos EA (2005) Nitric oxide preserves the glomerular protein permeability barrier by antagonizing superoxide. Kidney Int 68:2735\u20132744","journal-title":"Kidney Int"},{"key":"3082_CR52","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1111\/j.1365-2249.2010.04160.x","volume":"161","author":"R Bertelli","year":"2010","unstructured":"Bertelli R, Trivelli A, Magnasco A, Cioni M, Bodria M, Carrea A, Montobbio G, Barbano G, Ghiggeri GM (2010) Failure of regulation results in an amplified oxidation burst by neutrophils in children with primary nephrotic syndrome. Clin Exp Immunol 161:151\u2013158","journal-title":"Clin Exp Immunol"},{"key":"3082_CR53","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1681\/ASN.2004030172","volume":"16","author":"RJ Coward","year":"2005","unstructured":"Coward RJ, Foster RR, Patton D, Ni L, Lennon R, Bates DO, Harper SJ, Mathieson PW, Saleem MA (2005) Nephrotic plasma alters slit diaphragm-dependent signaling and translocates nephrin, podocin, and CD2 associated protein in cultured human podocytes. J Am Soc Nephrol 16:629\u2013637","journal-title":"J Am Soc Nephrol"},{"key":"3082_CR54","doi-asserted-by":"crossref","first-page":"1410","DOI":"10.1007\/s00467-005-1936-3","volume":"20","author":"WW Bakker","year":"2005","unstructured":"Bakker WW, van Dael CM, Pierik LJ, van Wijk JA, Nauta J, Borghuis T, Kapojos JJ (2005) Altered activity of plasma hemopexin in patients with minimal change disease in relapse. Pediatr Nephrol 20:1410\u20131415","journal-title":"Pediatr Nephrol"},{"key":"3082_CR55","doi-asserted-by":"crossref","first-page":"2140","DOI":"10.1681\/ASN.2007080940","volume":"19","author":"R Lennon","year":"2008","unstructured":"Lennon R, Singh A, Welsh GI, Coward RJ, Satchell S, Ni L, Mathieson PW, Bakker WW, Saleem MA (2008) Hemopexin induces nephrin-dependent reorganization of the actin cytoskeleton in podocytes. J Am Soc Nephrol 19:2140\u20132149","journal-title":"J Am Soc Nephrol"},{"key":"3082_CR56","doi-asserted-by":"crossref","first-page":"1041","DOI":"10.1007\/s00467-013-2452-5","volume":"28","author":"RJ Maas","year":"2013","unstructured":"Maas RJ, Deegens JK, Wetzels JF (2013) Serum suPAR in patients with FSGS: trash or treasure? Pediatr Nephrol 28:1041\u20131048","journal-title":"Pediatr Nephrol"},{"key":"3082_CR57","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1038\/nm1696","volume":"14","author":"C Wei","year":"2008","unstructured":"Wei C, Moller CC, Altintas MM, Li J, Schwarz K, Zacchigna S, Xie L, Henger A, Schmid H, Rastaldi MP, Cowan P, Kretzler M, Parrilla R, Bendayan M, Gupta V, Nikolic B, Kalluri R, Carmeliet P, Mundel P, Reiser J (2008) Modification of kidney barrier function by the urokinase receptor. Nat Med 14:55\u201363","journal-title":"Nat Med"},{"key":"3082_CR58","doi-asserted-by":"crossref","first-page":"952","DOI":"10.1038\/nm.2411","volume":"17","author":"C Wei","year":"2011","unstructured":"Wei C, El Hindi S, Li J, Fornoni A, Goes N, Sageshima J, Maiguel D, Karumanchi SA, Yap HK, Saleem M, Zhang Q, Nikolic B, Chaudhuri A, Daftarian P, Salido E, Torres A, Salifu M, Sarwal MM, Schaefer F, Morath C, Schwenger V, Zeier M, Gupta V, Roth D, Rastaldi MP, Burke G, Ruiz P, Reiser J (2011) Circulating urokinase receptor as a cause of focal segmental glomerulosclerosis. Nat Med 17:952\u2013960","journal-title":"Nat Med"},{"key":"3082_CR59","doi-asserted-by":"crossref","first-page":"1363","DOI":"10.1007\/s00467-013-2679-1","volume":"29","author":"G Cara-Fuentes","year":"2014","unstructured":"Cara-Fuentes G, Wei C, Segarra A, Ishimoto T, Rivard C, Johnson RJ, Reiser J, Garin EH (2014) CD80 and suPAR in patients with minimal change disease and focal segmental glomerulosclerosis: diagnostic and pathogenic significance. Pediatr Nephrol 29:1363\u20131371","journal-title":"Pediatr Nephrol"},{"key":"3082_CR60","doi-asserted-by":"crossref","first-page":"1304","DOI":"10.2215\/CJN.07680712","volume":"8","author":"ME Bock","year":"2013","unstructured":"Bock ME, Price HE, Gallon L, Langman CB (2013) Serum soluble urokinase-type plasminogen activator receptor levels and idiopathic FSGS in children: a single-center report. Clin J Am Soc Nephrol 8:1304\u20131311","journal-title":"Clin J Am Soc Nephrol"},{"key":"3082_CR61","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1038\/ki.2013.505","volume":"85","author":"B Meijers","year":"2014","unstructured":"Meijers B, Maas RJ, Sprangers B, Claes K, Poesen R, Bammens B, Naesens M, Deegens JK, Dietrich R, Storr M, Wetzels JF, Evenepoel P, Kuypers D (2014) The soluble urokinase receptor is not a clinical marker for focal segmental glomerulosclerosis. Kidney Int 85:636\u2013640","journal-title":"Kidney Int"},{"key":"3082_CR62","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1038\/ki.2013.544","volume":"85","author":"T Wada","year":"2014","unstructured":"Wada T, Nangaku M, Maruyama S, Imai E, Shoji K, Kato S, Endo T, Muso E, Kamata K, Yokoyama H, Fujimoto K, Obata Y, Nishino T, Kato H, Uchida S, Sasatomi Y, Saito T, Matsuo S (2014) A multicenter cross-sectional study of circulating soluble urokinase receptor in Japanese patients with glomerular disease. Kidney Int 85:641\u2013648","journal-title":"Kidney Int"},{"key":"3082_CR63","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1038\/ki.2013.546","volume":"85","author":"A Sinha","year":"2014","unstructured":"Sinha A, Bajpai J, Saini S, Bhatia D, Gupta A, Puraswani M, Dinda AK, Agarwal SK, Sopory S, Pandey RM, Hari P, Bagga A (2014) Serum-soluble urokinase receptor levels do not distinguish focal segmental glomerulosclerosis from other causes of nephrotic syndrome in children. Kidney Int 85:649\u2013658","journal-title":"Kidney Int"},{"key":"3082_CR64","doi-asserted-by":"crossref","first-page":"1553","DOI":"10.1007\/s00467-014-2808-5","volume":"29","author":"Y Harita","year":"2014","unstructured":"Harita Y, Ishizuka K, Tanego A, Sugawara N, Chikamoto H, Akioka Y, Tsurumi H, Miura K, Gotoh Y, Tsujita M, Yamamoto T, Horike K, Takeda A, Oka A, Igarashi T, Hattori M (2014) Decreased glomerular filtration as the primary factor of elevated circulating suPAR levels in focal segmental glomerulosclerosis. Pediatr Nephrol 29:1553\u20131560","journal-title":"Pediatr Nephrol"},{"key":"3082_CR65","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1038\/ki.2013.549","volume":"85","author":"D Schl\u00f6ndorff","year":"2014","unstructured":"Schl\u00f6ndorff D (2014) Are serum suPAR determinations by current ELISA methodology reliable diagnostic biomarkers for FSGS? Kidney Int 85:499\u2013501","journal-title":"Kidney Int"},{"key":"3082_CR66","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1038\/nrneph.2014.113","volume":"10","author":"JK Deegens","year":"2014","unstructured":"Deegens JK, Wetzels JF (2014) Glomerular disease: the search goes on: suPAR is not the elusive FSGS factor. Nat Rev Nephrol 10:431\u201343","journal-title":"Nat Rev Nephrol"},{"key":"3082_CR67","doi-asserted-by":"crossref","first-page":"1390","DOI":"10.1172\/JCI20402","volume":"113","author":"J Reiser","year":"2004","unstructured":"Reiser J, von Gersdorff G, Loos M, Oh J, Asanuma K, Giardino L, Rastaldi MP, Calvaresi N, Watanabe H, Schwarz K, Faul C, Kretzler M, Davidson A, Sugimoto H, Kalluri R, Sharpe AH, Kreidberg JA, Mundel P (2004) Induction of B7-1 in podocytes is associated with nephrotic syndrome. J Clin Invest 113:1390\u20131397","journal-title":"J Clin Invest"},{"key":"3082_CR68","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1093\/ndt\/gfr271","volume":"27","author":"M Shimada","year":"2012","unstructured":"Shimada M, Ishimoto T, Lee PY, Lanaspa MA, Rivard CJ, Roncal-Jimenez CA, Wymer DT, Yamabe H, Mathieson PW, Saleem MA, Garin EH, Johnson RJ (2012) Toll-like receptor 3 ligands induce CD80 expression in human podocytes via an NF-kappaB-dependent pathway. Nephrol Dial Transplant 27:81\u201389","journal-title":"Nephrol Dial Transplant"},{"key":"3082_CR69","doi-asserted-by":"crossref","first-page":"1439","DOI":"10.1093\/ndt\/gfs543","volume":"28","author":"T Ishimoto","year":"2013","unstructured":"Ishimoto T, Shimada M, Gabriela G, Kosugi T, Sato W, Lee PY, Rivard C, Lanaspa MA, Maruyama S, Garin EH, Johnson RJ (2013) Toll-like receptor 3 ligand, polyIC, induces proteinuria and glomerular CD80, and increases urinary CD80 in mice. Nephrol Dial Transplant 28:1439\u20131446","journal-title":"Nephrol Dial Transplant"},{"key":"3082_CR70","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1126\/science.1160062","volume":"322","author":"K Wing","year":"2008","unstructured":"Wing K, Onishi Y, Prieto-Martin P, Yamaguchi T, Miyara M, Fehervari Z, Nomura T, Sakaguchi S (2008) CTLA-4 control over Foxp3+ regulatory T cell function. Science 322:271\u2013275","journal-title":"Science"},{"key":"3082_CR71","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1111\/j.1600-065X.2008.00706.x","volume":"226","author":"DM Mosser","year":"2008","unstructured":"Mosser DM, Zhang X (2008) Interleukin-10: new perspectives on an old cytokine. Immunol Rev 226:205\u2013218","journal-title":"Immunol Rev"},{"key":"3082_CR72","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1007\/s00467-010-1676-x","volume":"26","author":"M Shimada","year":"2011","unstructured":"Shimada M, Araya C, Rivard C, Ishimoto T, Johnson RJ, Garin EH (2011) Minimal change disease: a \u201ctwo-hit\u201d podocyte immune disorder? Pediatr Nephrol 26:645\u2013649","journal-title":"Pediatr Nephrol"},{"key":"3082_CR73","doi-asserted-by":"crossref","first-page":"2246","DOI":"10.1097\/01.ASN.0000136312.46464.33","volume":"15","author":"J Reiser","year":"2004","unstructured":"Reiser J, Mundel P (2004) Danger signaling by glomerular podocytes defines a novel function of inducible B7-1 in the pathogenesis of nephrotic syndrome. J Am Soc Nephrol 15:2246\u20132248","journal-title":"J Am Soc Nephrol"},{"key":"3082_CR74","doi-asserted-by":"crossref","first-page":"2333","DOI":"10.1007\/s00467-014-2874-8","volume":"29","author":"G Cara-Fuentes","year":"2014","unstructured":"Cara-Fuentes G, Wasserfall CH, Wang H, Johnson RJ, Garin EH (2014) Minimal change disease: a dysregulation of the podocyte CD80-CTLA-4 axis? Pediatr Nephrol 29:2333\u20132340","journal-title":"Pediatr Nephrol"},{"key":"3082_CR75","doi-asserted-by":"crossref","first-page":"1074","DOI":"10.1053\/j.ajkd.2014.01.427","volume":"63","author":"K Ohl","year":"2014","unstructured":"Ohl K, Eberhardt C, Spink C, Zahn K, Wagner N, Eggermann T, Kemper MJ, Querfeld U, Hoppe B, Harendza S, Tenbrock K (2014) CTLA4 polymorphisms in minimal change nephrotic syndrome in children: a case\u2013control study. Am J Kidney Dis 63:1074\u20131075","journal-title":"Am J Kidney Dis"},{"key":"3082_CR76","doi-asserted-by":"crossref","first-page":"2800","DOI":"10.1093\/ndt\/gft381","volume":"28","author":"C Spink","year":"2013","unstructured":"Spink C, Stege G, Tenbrock K, Harendza S (2013) The CTLA-4+49GG genotype is associated with susceptibility for nephrotic kidney diseases. Nephrol Dial Transplant 28:2800\u20132805","journal-title":"Nephrol Dial Transplant"},{"key":"3082_CR77","doi-asserted-by":"crossref","first-page":"2416","DOI":"10.1056\/NEJMoa1304572","volume":"369","author":"CC Yu","year":"2013","unstructured":"Yu CC, Fornoni A, Weins A, Hakroush S, Maiguel D, Sageshima J, Chen L, Ciancio G, Faridi MH, Behr D, Campbell KN, Chang JM, Chen HC, Oh J, Faul C, Arnaout MA, Fiorina P, Gupta V, Greka A, Burke GW 3rd, Mundel P (2013) Abatacept in B7\u20131-positive proteinuric kidney disease. N Engl J Med 369:2416\u20132423","journal-title":"N Engl J Med"},{"key":"3082_CR78","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1038\/nrneph.2014.87","volume":"10","author":"A Fornoni","year":"2014","unstructured":"Fornoni A, Merscher S, Kopp JB (2014) Lipid biology of the podocyte\u2013new perspectives offer new opportunities. Nat Rev Nephrol 10:379\u2013388","journal-title":"Nat Rev Nephrol"},{"issue":"85","key":"3082_CR79","doi-asserted-by":"crossref","first-page":"85ra46","DOI":"10.1126\/scitranslmed.3002231","volume":"3","author":"A Fornoni","year":"2011","unstructured":"Fornoni A, Sageshima J, Wei C, Merscher-Gomez S, Aguillon-Prada R, Jauregui AN, Li J, Mattiazzi A, Ciancio G, Chen L, Zilleruelo G, Abitbol C, Chandar J, Seeherunvong W, Ricordi C, Ikehata M, Rastaldi MP, Reiser J, Burke GW 3rd (2011) Rituximab targets podocytes in recurrent focal segmental glomerulosclerosis. Sci Transl Med 3(85):85ra46. doi: 10.1126\/scitranslmed.3002231","journal-title":"Sci Transl Med"},{"key":"3082_CR80","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1038\/nm.2261","volume":"17","author":"LC Clement","year":"2011","unstructured":"Clement LC, Avila-Casado C, Mac\u00e9 C, Soria E, Bakker WW, Kersten S, Chugh SS (2011) Podocyte-secreted angiopoietin-like-4 mediates proteinuria in glucocorticoid-sensitive nephrotic syndrome. Nat Med 17:117\u2013122","journal-title":"Nat Med"},{"key":"3082_CR81","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1053\/j.ajkd.2011.07.024","volume":"59","author":"SS Chugh","year":"2012","unstructured":"Chugh SS, Clement LC, Mac\u00e9 C (2012) New insights into human minimal change disease: lessons from animal models. Am J Kidney Dis 59:284\u2013292","journal-title":"Am J Kidney Dis"},{"key":"3082_CR82","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1038\/nm.3396","volume":"20","author":"LC Clement","year":"2014","unstructured":"Clement LC, Mac\u00e9 C, Avila-Casado C, Joles JA, Kersten S, Chugh SS (2014) Circulating angiopoietin-like 4 links proteinuria with hypertriglyceridemia in nephrotic syndrome. Nat Med 20:37\u201346","journal-title":"Nat Med"},{"key":"3082_CR83","doi-asserted-by":"crossref","first-page":"2393","DOI":"10.1681\/ASN.2014030267","volume":"25","author":"C Mac\u00e9","year":"2014","unstructured":"Mac\u00e9 C, Chugh SS (2014) Nephrotic syndrome: components, connections, and angiopoietin-like 4-related therapeutics. J Am Soc Nephrol 25:2393\u20132398","journal-title":"J Am Soc Nephrol"}],"container-title":["Pediatric Nephrology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00467-015-3082-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00467-015-3082-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00467-015-3082-x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,5,6]],"date-time":"2022-05-06T12:48:30Z","timestamp":1651841310000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00467-015-3082-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,4,30]]},"references-count":83,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2016,2]]}},"alternative-id":["3082"],"URL":"https:\/\/doi.org\/10.1007\/s00467-015-3082-x","relation":{},"ISSN":["0931-041X","1432-198X"],"issn-type":[{"value":"0931-041X","type":"print"},{"value":"1432-198X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,4,30]]}}}